Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Petry

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Gynecologic Oncology|March 23, 2011
Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytologyK Ulrich Petry, Dietmar Schmidt, Sarah Scherbring, et al.
GMS Health Technology Assessment|February 4, 2011
Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in GermanyGaby Sroczynski, Petra Schnell-Inderst, Nikolai Mühlberger, et al.
International Journal of Cancer|April 6, 2006
Overview of the European and North American studies on HPV testing in primary cervical cancer screeningJack Cuzick, Christine Clavel, Karl-Ulrich Petry, et al.
Vaccine|January 17, 2016
Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccinesPierre Van Damme, Paolo Bonanni, F Xavier Bosch, et al.
Vaccine|July 28, 2016
Corrigendum to "Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines" [Vaccine 34 (2016) 757-761]Pierre Van Damme, Paolo Bonanni, F Xavier Bosch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 1, 2006
[Syphilis. Guideline of the German Sexually Transmitted Diseases Society fo diagnosis and therapy of syphilis]Helmut Schöfer, Norbert H Brockmeyer, Hans-Jochen Hagedorn, et al.
Journal of Lower Genital Tract Disease|May 7, 2013
Characterization of squamous cell cancers of the vulvar anterior fourchette by human papillomavirus, p16INK4a, and p53Miriam Reuschenbach, Judith Roos, Dimitrios Panayotopoulos, et al.
Journal of Medical Virology|May 8, 2008
Comparison of the performance of different HPV genotyping methods for detecting genital HPV typesStefanie J Klug, Anco Molijn, Betti Schopp, et al.
Obstetrics and Gynecology|February 3, 2004
ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trialFrancisco Garcia, Karl Ulrich Petry, Laila Muderspach, et al.
Journal of Lower Genital Tract Disease|August 5, 2014
Utility and Reproducibility of the International Federation for Cervical Pathology and Colposcopy Classification of Transformation Zones in Daily Practice: A Multicenter Study of the German Colposcopy NetworkAlexander Luyten, Nina Buttmann-Schweiger, Ingke Hagemann, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|March 23, 2011
Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytologyK Ulrich Petry, Dietmar Schmidt, Sarah Scherbring, et al.
GMS Health Technology Assessment|February 4, 2011
Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in GermanyGaby Sroczynski, Petra Schnell-Inderst, Nikolai Mühlberger, et al.
International Journal of Cancer|April 6, 2006
Overview of the European and North American studies on HPV testing in primary cervical cancer screeningJack Cuzick, Christine Clavel, Karl-Ulrich Petry, et al.
Vaccine|January 17, 2016
Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccinesPierre Van Damme, Paolo Bonanni, F Xavier Bosch, et al.
Vaccine|July 28, 2016
Corrigendum to "Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines" [Vaccine 34 (2016) 757-761]Pierre Van Damme, Paolo Bonanni, F Xavier Bosch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 1, 2006
[Syphilis. Guideline of the German Sexually Transmitted Diseases Society fo diagnosis and therapy of syphilis]Helmut Schöfer, Norbert H Brockmeyer, Hans-Jochen Hagedorn, et al.
Journal of Lower Genital Tract Disease|May 7, 2013
Characterization of squamous cell cancers of the vulvar anterior fourchette by human papillomavirus, p16INK4a, and p53Miriam Reuschenbach, Judith Roos, Dimitrios Panayotopoulos, et al.
Journal of Medical Virology|May 8, 2008
Comparison of the performance of different HPV genotyping methods for detecting genital HPV typesStefanie J Klug, Anco Molijn, Betti Schopp, et al.
Obstetrics and Gynecology|February 3, 2004
ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trialFrancisco Garcia, Karl Ulrich Petry, Laila Muderspach, et al.
Journal of Lower Genital Tract Disease|August 5, 2014
Utility and Reproducibility of the International Federation for Cervical Pathology and Colposcopy Classification of Transformation Zones in Daily Practice: A Multicenter Study of the German Colposcopy NetworkAlexander Luyten, Nina Buttmann-Schweiger, Ingke Hagemann, et al.
Pageof 8